Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Mol Psychiatry. 2015 Jul 28;21(5):650–655. doi: 10.1038/mp.2015.98

Table 1.

Top results from the prespecified gene set analysis showing all associations with a nominal P < 0.05

Gene/set Annotation/frequency category Variants in affected/unaffected OR P-value P-value (adjusted)
Cav2 adaptors Damaging/mac1 22/11 2.58 0.0008 0.049
Neuronal synaptic vesicle Lof/maf05 10/3 4.30 0.0171 0.780
Cav2 adaptors Damaging/maf05 41/35 1.51 0.0174 0.785
Neuronal synaptic vesicle Lof/maf01 10/3 4.30 0.0187 0.801
Neuronal PSD Lof/mac1 32/32 1.29 0.0211 0.834
Cav2 adaptors Damaging/maf01 32/25 1.65 0.0221 0.843
Neuronal synaptic vesicle Lof/mac1 8/3 3.44 0.0224 0.848
Neuronal early endosomes Damaging/mac1 4/1 5.16 0.0240 0.866
Neuronal plasma membrane Damaging/mac1 20/11 2.34 0.0244 0.875
Neuronal plasma membrane Damaging/maf01 29/23 1.63 0.0279 0.907
Neuronal plasma membrane Damaging/maf05 38/34 1.44 0.0390 0.954
Neuronal Golgi Damaging/mac1 11/9 1.58 0.0421 0.966
MDD GWAS (P < 1 × 10−4) Lof/mac1 8/4 2.58 0.0495 0.979
Neuronal ARC Damaging/maf05 46/40 1.48 0.0499 0.981

Abbreviations: GWAS, genome-wide association studies; MDD, major depressive disorder; OR, odds ratio; PSD, postsynaptic density.